Sanford Barsky, M.D., University of Nevada School of Medicine and Nevada Cancer Institute faculty member publishes scientific paper in the journal Nature

Paper highlights results of a transgenic mouse study directly applicable to human breast cancer tumor study

RENO/LAS VEGAS, Nev. — Sanford Barsky, M.D., who holds faculty positions at the University of Nevada School of Medicine as chair of the pathology department and Nevada Cancer Institute chief of pathology, is part of a team that will have a paper on transgenic mouse mammary tumors with direct relevance to human breast cancer published in the October 22 issue of the scientific journal Nature.

The article, "Pten in stromal fibroblasts suppresses mammary epithelial tumours," shows that a key signaling pathway that operates in mammary gland connective tissue cells helps to suppress the development of mammary tumors. This study is important because it helps tease apart the complex links between tumor microenvironment and cancer development.

It had been thought that the connective tissue surrounding tumors — also known as the tumor microenvironment - is important for helping the tumor to grow and survive, but it was not clear just how. This study revealed that deletion of the tumour suppressor gene Pten in fibroblasts - connective tissue cells - of mammary glands leads to the accelerated development of mammary tumors in mice. Furthermore, tumor development goes hand-in-hand with other changes in the local cellular environment, such as increased blood vessel formation and immune cell infiltration.

Pten loss and related changes in gene expression can also be observed in the connective tissue of breast cancers in women, suggesting that the signaling system operates in humans as well as mice. The team also highlights Pten's influence on a transcription factor called Ets2 as being critical for Pten's tumour suppressive functions in the connective tissue.

Barsky, who serves as chief of pathology for Nevada Cancer Institute in Las Vegas and vice president, academic liaison to University of Nevada, Reno, is also professor and chair of the Department of Pathology of the University of Nevada School of Medicine. He joined both the School of Medicine and the Nevada Cancer Institute in September 2009.

Barsky, who has a strong research and clinical background, has published more than 150 peer reviewed articles and more than 200 abstracts.

Nature is a prominent British scientific journal, published since 1869, which focuses on publishing original research articles across a wide range of science fields, including new advances and original research studies.

Pten in stromal fibroblasts suppresses mammary epithelial tumours

Anthony J. Trimboli 1,2*, Carmen Z. Cantemir-Stone 3*, Fu Li1, 3*, Julie A. Wallace 3, Anand Merchant 3, Nicholas Creasap 1,2, John C. Thompson 1,2, Enrico Caserta 1,2, Hui Wang 1,2, Jean-Leon Chong 1,2, Shan Naidu 1,2,4, Guo Wei 1,3, Sudarshana M. Sharma 3, Julie A. Stephens 5, Soledad A. Fernandez 5, Metin N. Gurcan 6, Michael B. Weinstein 1,2, Sanford H. Barsky 7{, Lisa Yee8, Thomas J. Roso l4, Paul C. Stromberg 4, Michael L. Robinson9 {, Francois Pepin 10,11, Michael Hallett 10,11, Morag Park 10,12, Michael C. Ostrowski 3,13 & Gustavo Leone 1,2,13

  1. Department of Molecular Genetics, College of Biological Sciences
  2. Department of Molecular Virology, Immunology and Medical Genetics
  3. Department of Molecular and Cellular Biochemistry, College of Medicine
  4. Department of Veterinary Biosciences, College of Veterinary Medicine
  5. Center for Biostatistics, Office of Health Sciences
  6. Department of Biomedical Informatics
  7. Department of Pathology and
  8. Department of Surgery, School of Medicine, The Ohio State University, Columbus, Ohio 43210, USA.
  9. Center for Molecular and Human Genetics, Columbus Children's Research Institute, Columbus, Ohio 43205, USA.
  10. Department of Biochemistry, Rosalind and Morris Goodman Cancer Center
  11. McGill Center for Bioinformatics,
  12. Department of Oncology, McGill University, Québec H3A 1A1, Canada.
  13. Tumor Microenvironment Program, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA. {Present addresses: Department of Pathology, University of Nevada School of Medicine, Reno, Nevada 89557, and Nevada Cancer Institute, Las Vegas, Nevada 89135, USA (S.H.B.); Department of Zoology, Miami University, Oxford, Ohio 45056, USA (M.L.R.).

*These authors contributed equally to this work.

About Nevada Cancer Institute

Nevada Cancer Institute (NVCI) is the official cancer institute for the State of Nevada. A nonprofit organization, NVCI is committed to reducing the burden of cancer by pursuing the development of a comprehensive cancer center, as defined by the National Cancer Institute. Through the knowledge and expertise of the finest scientists, clinicians, educators and caregivers, the Institute provides hope to communities in Nevada, the southwest and beyond through research, education, early detection, prevention and high quality patient care. NVCI is striving for a future without cancer that is achieved through innovative and collaborative research in basic, clinical and population science. For more information, call (702) 822-LIFE (5433).


Media Contacts

Julie Ardito, APR
Senior Director, Advancement and Engagement
Office: (775) 784-6006

Tessa Bowen, MPA
Communications Manager, Advancement and Engagement
Office: (775) 682-9254

The University of Nevada, Reno School of Medicine, Nevada's first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Established in 1969, UNR Med is improving the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion.